- Home
- Publications
- Publication Search
- Publication Details
Title
A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Canadian Journal of Gastroenterology and Hepatology
Volume 2022, Issue -, Pages 1-15
Publisher
Hindawi Limited
Online
2022-03-21
DOI
10.1155/2022/5389044
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of statin use on the risk and prognosis of hepatocellular carcinoma
- (2021) Jianfeng Wang et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives
- (2021) Szu-Yi Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis
- (2020) Xiaofei Li et al. BMC GASTROENTEROLOGY
- Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis
- (2019) David E. Kaplan et al. GASTROENTEROLOGY
- Risk Factors for Severe Liver Disease in Patients With Type 2 Diabetes
- (2019) Karl Björkström et al. Clinical Gastroenterology and Hepatology
- Statin use and risk of liver cancer: evidence from two population‐based studies
- (2019) Kim Tu Tran et al. INTERNATIONAL JOURNAL OF CANCER
- Epidemiological and etiological variations in hepatocellular carcinoma
- (2019) Evangelista Sagnelli et al. INFECTION
- Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population
- (2019) Tracey G. Simon et al. ANNALS OF INTERNAL MEDICINE
- Statin Use and the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
- (2019) Myung Ji Goh et al. HEPATOLOGY
- Statin Use is Protective Against Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease
- (2019) Margarita N. German et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma
- (2019) Sang-Wook Yi et al. BRITISH JOURNAL OF CANCER
- The effect of statin use on the incidence of prostate cancer: A population-based nested case-control study
- (2018) David E. Dawe et al. INTERNATIONAL JOURNAL OF CANCER
- Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study
- (2018) Gyuri Kim et al. JOURNAL OF HEPATOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Liver carcinogenesis by FOS-dependent inflammation and cholesterol dysregulation
- (2017) Latifa Bakiri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis
- (2017) An Tang et al. Abdominal Radiology
- Statin Use and Survival with Early-Stage Hepatocellular Carcinoma
- (2016) C. Y. Jeon et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases
- (2016) Ashwin N. Ananthakrishnan et al. Clinical Gastroenterology and Hepatology
- Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C–Related Compensated Cirrhosis
- (2016) Arpan Mohanty et al. GASTROENTEROLOGY
- Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES
- (2016) Tracey G. Simon et al. HEPATOLOGY
- Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study
- (2016) Gyuri Kim et al. INTERNATIONAL JOURNAL OF CANCER
- Mechanisms of HBV-induced hepatocellular carcinoma
- (2016) Massimo Levrero et al. JOURNAL OF HEPATOLOGY
- Statins and Reduced Risk of Liver Cancer: Evidence for Confounding: Table 1.
- (2016) Gary D. Friedman et al. JNCI-Journal of the National Cancer Institute
- Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma
- (2016) Yao-Yao Zhou et al. Oncotarget
- Statins and Reduced Risk of Liver Cancer: Evidence for Confounding: Table 1.
- (2016) Gary D. Friedman et al. JNCI-Journal of the National Cancer Institute
- Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells
- (2015) Lee-Won Chong et al. BMC GASTROENTEROLOGY
- Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES
- (2015) Adeel A. Butt et al. HEPATOLOGY
- Menopausal hormone therapy use and risk of primary liver cancer in the clinical practice research datalink
- (2015) Katherine A. McGlynn et al. INTERNATIONAL JOURNAL OF CANCER
- Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis
- (2015) John Chen Hsiang et al. JOURNAL OF HEPATOLOGY
- Statin Use and Risk of Primary Liver Cancer in the Clinical Practice Research Datalink
- (2015) K. A. McGlynn et al. JNCI-Journal of the National Cancer Institute
- Statin Use and Risk of Primary Liver Cancer in the Clinical Practice Research Datalink
- (2015) K. A. McGlynn et al. JNCI-Journal of the National Cancer Institute
- Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy
- (2014) Laura Galli et al. AIDS
- Statin use and risk of hepatocellular carcinoma in a U.S. population
- (2014) Katherine A. McGlynn et al. Cancer Epidemiology
- Statin Use in Patients with Cirrhosis: A Retrospective Cohort Study
- (2014) Sonal Kumar et al. DIGESTIVE DISEASES AND SCIENCES
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Mutational landscape of HCC—the end of the beginning
- (2014) Augusto Villanueva et al. Nature Reviews Clinical Oncology
- Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden
- (2014) Linda Björkhem-Bergman et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Novel prospects of statins as therapeutic agents in cancer
- (2014) Simona Pisanti et al. PHARMACOLOGICAL RESEARCH
- Statin use and risk of liver cancer: an update meta-analysis
- (2014) M. Shi et al. BMJ Open
- Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies
- (2013) Yanqiong Liu et al. CANCER CAUSES & CONTROL
- Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
- (2013) Yu-Tse Tsan et al. JOURNAL OF CLINICAL ONCOLOGY
- Statins and primary liver cancer
- (2012) Danitza Pradelli et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
- (2012) Siddharth Singh et al. GASTROENTEROLOGY
- The pleiotropic effects and therapeutic potential of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in malignancies: A comprehensive review
- (2012) Orlando Santana et al. Journal of Cancer Research and Therapeutics
- Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
- (2012) Yu-Tse Tsan et al. JOURNAL OF CLINICAL ONCOLOGY
- Potential for statins in the chemoprevention and management of hepatocellular carcinoma
- (2012) Amedeo Lonardo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- MYC Phosphorylation, Activation, and Tumorigenic Potential in Hepatocellular Carcinoma Are Regulated by HMG-CoA Reductase
- (2011) Z. Cao et al. CANCER RESEARCH
- Hepatitis C virus: How genetic variability affects pathobiology of disease
- (2011) Kazuaki Chayama et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Statins and Risk of Cancer
- (2011) Claudio Marelli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Statin Use and the Risk of Liver Cancer: A Population-Based Case–Control Study
- (2010) Hui-Fen Chiu et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy
- (2010) Stephen A. Harrison et al. HEPATOLOGY
- Simvastatin inhibits cell growth and induces apoptosis and G0/G1 cell cycle arrest in hepatic cancer cells
- (2010) Relja INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- 835 Insulin Treatment and the Risk of Hepatocellular Carcinoma in Patients with Diabetes
- (2009) Hashem B. El-Serag et al. GASTROENTEROLOGY
- Statins potentiate thein vitroanti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development
- (2009) Leen Delang et al. HEPATOLOGY
- Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression
- (2009) Xiaoying Zhang et al. HEPATOLOGY
- Nonstructural 5A protein activates β-catenin signaling cascades: Implication of hepatitis C virus-induced liver pathogenesis
- (2009) Chul-Yong Park et al. JOURNAL OF HEPATOLOGY
- Pravastatin use and cancer risk: a meta-analysis of individual patient data from long-term prospective controlled trials in Japan
- (2009) Yasuyuki Matsushita et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started